RSS Feed for This PostCurrent Article

Hythiam Announces Peer-Reviewed Publication Of Randomized, Double-Blind, Placebo-Controlled Study

Hythiam, Inc. announced that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA Treatment Program on methamphetamine dependent subjects were published in the Journal of Psychopharmacology, a peer-reviewed, international journal that publishes original research and review articles on …

More: continued here

Trackback URL

Sorry, comments for this entry are closed at this time.